XML 22 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value (Tables)
3 Months Ended
Mar. 31, 2013
Fair Value [Abstract]  
Fair value of assets and liabilities measured on a recurring basis
The following tables summarize the valuation of our financial instruments by pricing observability levels as of March 31, 2013 and December 31, 2012:

   
March 31, 2013
 
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
 
Total
 
   
(in thousands)
                                 
Money markets
 
$
216,435
 
 
$
 
 
$
   
$
216,435
 
U.S. Treasury Bills
   
     
1,082,237
     
     
1,082,237
 
U.K. Treasury Bills
   
     
117
     
     
117
 
Equity securities
                               
Growth
   
141,695
     
     
     
141,695
 
Value
   
32,440
     
3,704
     
     
36,144
 
Multi-asset and asset allocation
   
55,981
     
     
     
55,981
 
Other(1)
   
56,137
     
     
     
56,137
 
Fixed Income securities
 
 
 
 
 
 
 
 
 
 
           
Taxable(2)
   
147,024
     
2,992
     
     
150,016
 
Tax-exempt(3)
   
5,701
     
791
     
     
6,492
 
Derivatives
   
821
     
2,110
     
     
2,931
 
Long exchange-traded options
   
13,772
     
     
     
13,772
 
Private equity
 
 
5,816
 
 
 
 
 
 
74,853
     
80,669
 
Total assets measured at fair value
 
$
675,822
   
$
1,091,951
   
$
74,853
   
$
1,842,626
 
                                 
Securities sold not yet purchased
                               
Short equities – corporate
 
$
57,588
   
$
   
$
   
$
57,588
 
Short exchange-traded options
   
11,845
     
     
     
11,845
 
Derivatives
   
1,336
     
2,745
     
     
4,081
 
Total liabilities measured at fair value
 
$
70,769
 
 
$
2,745
 
 
$
   
$
73,514
 
 
 
   
December 31, 2012
 
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
 
Total
 
   
(in thousands)
                                 
Money markets
 
$
170,120
 
 
$
 
 
$
   
$
170,120
 
U.S. Treasury Bills
   
     
1,537,150
     
     
1,537,150
 
U.K. Treasury Bills
   
     
125
     
     
125
 
Equity securities
                               
Growth
   
125,242
     
     
     
125,242
 
Value
   
36,126
     
     
     
36,126
 
Multi-asset and asset allocation
   
59,449
     
     
     
59,449
 
Other(1)
   
39,702
     
     
     
39,702
 
Fixed Income securities
 
 
 
 
 
 
 
 
 
 
           
Taxable(2)
   
177,635
     
1,219
     
     
178,854
 
Tax-exempt(3)
   
5,661
     
797
     
     
6,458
 
Derivatives
   
64
     
2,561
     
     
2,625
 
Long exchange-traded options
   
15,087
     
     
     
15,087
 
Private equity
 
 
7,695
 
 
 
 
 
 
76,953
     
84,648
 
Total assets measured at fair value
 
$
636,781
   
$
1,541,852
   
$
76,953
   
$
2,255,586
 
                                 
Securities sold not yet purchased
                               
Short equities – corporate
 
$
54,370
   
$
   
$
   
$
54,370
 
Short exchange-traded options
   
9,197
     
     
     
9,197
 
Other
   
271
     
     
     
271
 
Derivatives
   
1,598
     
5,472
     
     
7,070
 
Total liabilities measured at fair value
 
$
65,436
 
 
$
5,472
 
 
$
   
$
70,908
 
 

 (1)
Primarily long positions in corporate equities traded through our options desk.
 (2)
Primarily corporate and government securities.
 (3)
Primarily municipal bonds.
Fair value measurement Level 3 reconciliation
The following table summarizes the change in carrying value associated with Level 3 financial instruments carried at fair value:

   
Three Months Ended March 31,
 
   
2013
  
2012
 
 
(in thousands)
 
        
Balance as of beginning of period
 $76,953  $64,466 
Transfer (out) in, net
     (13,548 )
Purchases
  10   1,845 
Sales
      
Realized gains (losses), net
      
Unrealized gains (losses), net
  (2,110 )  5,472 
Balance as of end of period
 $74,853  $58,235 
Information about Level 3 fair value measurements
The following table provides quantitative information about Level 3 fair value measurements:

 
 
Fair Value as of March 31, 2013
 
Valuation Technique
 
Unobservable Input
 
Range
 
   
(in thousands)
        
Private Equity:
                    
                     
Technology, Media and Telecommunications
 
$
23,256
 
Market comparable companies
 
Revenue multiple
   
2.5 – 6.0
 
             
Discount rate
   
18%
 
             
Discount years
   
1.75
 
                      
Healthcare and Cleantech
 
$
14,871
 
Market comparable companies
 
Revenue multiple(1)
   
0.6 – 68.7
 
             
R&D multiple(1)
   
0.9 – 35.0
 
             
Discount for lack of marketability and risk factors
   
30-60%
 
 

(1)
The median for the Healthcare and Cleantech revenue multiple is 7.8; the median R&D multiple is 5.2.